Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.19.2
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Operating expenses:    
Research and development $ 4,313,900 $ 2,743,700
General and administrative 1,910,100 1,466,300
Total operating expenses 6,224,000 4,210,000
Loss from operations (6,224,000) (4,210,000)
Other income (expenses), net:    
Interest income (expense), net 16,500 (2,100)
Loss before income taxes (6,207,500) (4,212,100)
Income taxes (2,400) (2,400)
Net loss and comprehensive loss (6,209,900) (4,214,500)
Accrued dividends on Series B Preferred stock (302,500) (273,500)
Net loss attributable to common stockholders $ (6,512,400) $ (4,488,000)
Basic and diluted net loss attributable to common stockholders per common share $ (0.15) $ (0.20)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share 42,622,965 22,987,066